The market for veterinary pain management was valued at USD 1,352.1 Million in 2021 and is anticipated to grow at a 6.6% CAGR in terms of revenue over the forecast period. Some of the major reasons fueling market revenue growth include rising meat and milk product consumption, rising veterinary medicine approvals, rising zoonotic disease prevalence, and rising government and other organisation activities. The practise of diagnosing, preventing, and treating pain in animals that is brought on by issues with their essential organs, physical injuries, their spines and central nervous systems, or surgical procedures is known as veterinary pain management.
The report also offers estimations and predictions about the market segment and sub-segments exhibiting promising growth in the forecast timeline. The report also provides deeper insights into the technological advancements, industrial landscape, and emerging product and technological developments in the Veterinary Pain Management market. It offers fruitful insights into the business sphere to help businesses capitalize on the lucrative growth opportunities.
The section on the competitive landscape offers valuable and actionable insights related to the business sphere of the Veterinary Pain Management market, covering extensive profiling of the key market players. The report offers information about market share, product portfolio, pricing analysis, and strategic alliances such as mergers and acquisitions, joint ventures, collaborations, partnerships, product launches and brand promotions, among others. The report also discusses the initiatives taken by the key companies to combat the impact of the COVID-19 pandemic.
The leading market contenders listed in the report are:
Vetoquinol, Merck & Co., Inc., Ceva., Zoetis, Boehringer Ingelheim International GmbH., Pfizer Inc., Eli Lilly and Company, LABINDIA Healthcare Pvt. Ltd., Chanelle Pharma,and Elanco
Emergen Research has segmented the global Veterinary Pain Management market on the basis of type, application, end-use, and region:
Segments Covered in this report are:
Drug Type Outlook (Revenue, USD Million; 2019-2030)
NSAIDs
Opioids
Anesthetics
Others
Route of Administration Outlook (Revenue, USD Million; 2019-2030)
Oral
Parenteral
Others
Application Outlook (Revenue, USD Million; 2019-2030)
Osteoarthritis and Joint Pain
Cancer
Others
The various regions analyzed in the report include:
North America (U.S., Canada)
Europe (U.K., Italy, Germany, France, Rest of EU)
Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)
Latin America (Chile, Brazil, Argentina, Rest of Latin America)
Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)
Key Objectives of the Report:
Analysis and estimation of the Veterinary Pain Management Market size and share for the projected period of 2022-2030
Extensive analysis of the key players of the market by SWOT analysis and Porter’s Five Forces analysis to impart a clear understanding of the competitive landscape
Study of current and emerging trends, restraints, drivers, opportunities, challenges, growth prospects, and risks of the global Veterinary Pain Management Market
Analysis of the growth prospects for the stakeholders and investors through the study of the promising segments
Strategic recommendations to the established players and new entrants to capitalize on the emerging growth opportunities
